LENALIDOMIDE vs LETERMOVIR: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LENALIDOMIDE vs LETERMOVIR: Safety Overview
| Metric | LENALIDOMIDE | LETERMOVIR |
|---|---|---|
| Total FAERS Reports | 349,955 | 1,416 |
| Deaths Reported | 35,942 | 252 |
| Death Rate | 10.3% | 17.8% |
| Hospitalizations | 86,495 | 398 |
| Average Patient Age | 69.9 yrs | 46.6 yrs |
| % Female Patients | 50.0% | 42.7% |
| FDA Approval Date | Aug 3, 2023 | Aug 30, 2024 |
| Manufacturer | Padagis US LLC | Merck Sharp & Dohme LLC |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |